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ABSTRACT
Micro-computed tomographic evaluation of bone healing 
following dental extraction in beagle dogs treated with 
zoledronic acid
Seung-Won Chung
Department of Dentistry
The Graduate School, Yonsei University
(Directed by Professor Young-Soo Jung, DDS, PhD)
Medication-related osteonecrosis of the jaws (MRONJ) is a rare but potentially severe 
side effect of long-term use of antiresorptive and antiangiogenic agents. However, the 
etiopathology of this condition is still not fully understood. In order to establish the 
pathogenesis of this disease, a reliable and reproducible animal model is required. The 
purpose of this study was to induce clinical features of MRONJ after tooth extraction in 
zoledronate treated beagle dogs, and analyze bone healing using micro-CT. The results 
are as follows;
iv
1. In the experimental animal, extraction sites showed exposed bone with impaired 
wound healing at both post-extraction 1 month and 2 months.
2. Extraction sockets of the experimental animal showed significantly lower values 
of bone volume fraction, trabecular number, and trabecular thickness than those 
of the control animal at both post-extraction 1 month and 2 months. 
3. Septal bone of the experimental animal showed significantly lower values of 
bone volume fraction than those of the control animal at both post-extraction 1 
month and 2 months. 
4. Cortical bone of the experimental animal showed significantly lower values of 
cortical area fraction, higher values of cortical porosity and average pore volume
than those of the control animal at both post-extraction 1 month and 2 months. 
5. In the experimental animal, new bone formation was noted outside buccal and 
lingual cortex at both post-extraction 1 month and 2 months.
Although the sample size of this study is limited, this study introduces beagle dog as a 
promising large animal model for MRONJ. From this model, microarchitectural 
morphometric changes of bone healing after tooth extraction were evaluated. This animal 
model can be used for further research in the fields of MRONJ etiopathology and 
treatment.
Key words: MRONJ, large animal model, micro-CT
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I. INTRODUCTION
Bisphosphonates have been widely used for the treatment of osteoporosis and other 
various bone disease including skeletal complications induced by cancer metastasis by 
inhibiting bone turnover. (Delmas, 2005; Hatoum et al., 2008; Sambrook and Cooper, 
2006) However, osteonecrosis of the jaws (ONJ), a rare but potentially severe side effect 
associated with bisphosphonate administration, has been reported continuously since 
2003. (Marx, 2003) Therefore, American Association of Oral and Maxillofacial Surgeons
(AAOMS) published a Position Paper on bisphosphonate-related osteonecrosis of the 
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jaws (BRONJ) in 2007 and updated it in 2009. (Advisory Task Force on Bisphosphonate-
Related Ostenonecrosis of the Jaws and Maxillofacial, 2007; Ruggiero et al., 2009) With 
growing number of ONJ associated with other antiresorptive and antiangiogenic agents, 
AAOMS proposed the term medication-related osteonecrosis of the jaw (MRONJ) in 
2014. (Ruggiero et al., 2014)
The current definition of MRONJ is based on its clinical characteristics and medical 
history; exposed bone or bone that can be probed through an intraoral or extraoral fistula
in the maxillofacial region that has persisted for more than eight weeks, with current or 
previous treatment with antiresorptive or antiangiogenic agents, and absence of radiation 
therapy history to the jaws or obvious metastatic disease to the jaws. (Ruggiero et al., 
2014) This definition, however, does not include pathogenesis or histopathology. (Pautke 
et al., 2010)  
Despite the efforts to establish the pathogenesis of this disease, the etiopathology of 
this condition is not yet fully understood. (Allen and Burr, 2009; Otto et al., 2010; 
Ruggiero et al., 2014; Subramanian et al., 2011) Although MRONJ has been reported to 
occur spontaneously, dental extraction has been considered as a common risk factor that 
increases the incidence of the disease. (Ruggiero et al., 2009; Sonis et al., 2009) There 
have been various studies to develop clinical features of MRONJ in small animal models, 
such as mice and rodents. (Barba-Recreo et al., 2014; Biasotto et al., 2010; Hokugo et al., 
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2010; Lopez-Jornet et al., 2010; Maahs et al., 2011; Sharma et al., 2013; Sonis et al., 2009)
However, these small animal models have a crucial limitation due to anatomical 
divergence to human that they lack intracortical remodeling. (Kubek et al., 2010; Lelovas 
et al., 2008) Larger animal models, such as dogs, minipigs, and sheep, are considered 
more appropriate for the study of MRONJ because the nature of the disease affects 
cortical bone as well as trabecular bone. (Allen et al., 2013; Jee and Yao, 2001) Especially, 
canine bones have similar bone turnover rates to human bones. (Aerssens et al., 1998; 
Allen and Burr, 2008)
Recent studies on developing a large animal model for MRONJ have shown variable 
success rates. (Pautke et al., 2012; Voss et al., 2015; Voss et al., 2016) Although beagle 
dog is an established large animal model for investigating skeletal changes, reliable 
induction of exposed bone has not yet been developed. (Allen et al., 2013; Allen et al., 
2010; Allen et al., 2011)
The purpose of this study was to induce clinical features of MRONJ after tooth 
extraction in zoledronate treated beagle dogs, and analyze bone healing by using micro-
computed tomography (micro-CT). 
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II. MATERIALS AND METHODS
All animal procedures were performed under protocols approved by the institutional 
animal research ethics committee at CRONEX Co., Ltd (CRONEX-IACUC: 201506003).
1. Pilot study
One skeletally mature male beagle dog (9-month-old) with weight of 11.9kg was used 
in the pilot study. Following 1 week of acclimatization, the animal received zoledronic 
acid (Zometa®) intravenously at a dose of 0.067mg/kg every 10 days. Zoledronic acid 
was dissolved in saline and administered in a 10mL volume by using a 20-gauge catheter 
in the cephalic vein over 15-minute period under sedation. This dosage was determined 
according to the following factors; (1) oncological zoledronic dose in human is 
0.067mg/kg/month (Clemons et al., 2006) and (2) relatively higher bone turnover rate in 
dogs (Cardaropoli et al., 2003). Therefore, the frequency of injection was about three 
times as frequently as it is used clinically. 
After 3 months of injection, the animal underwent dental extraction of the lower left 
premolar 2, 3, 4 and molar 1 under sedation as a surgical intervention. Zoledronic acid 
injection was continued every 10 days for 1 month, and the animal underwent dental 
extraction of the lower right premolar 2, 3, 4 and molar 1. This study design was to allow 
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two different post-extraction times (post-extraction 1 month and 2 months) to be 
evaluated in the same animal. 
For dental extractions, the animal was anesthetized using Propofol (8mg/kg) 
intravenously and intubated with continuous isofluorane during the surgery. After 
intraoral regional block of the inferior alveolar nerve, the crown of the tooth was split in 
the middle using high speed dental drill and each of the two roots was removed using 
dental forceps. After extraction, the extraction sockets were left open without any sutures. 
1 month later, the animal was sacrificed for macroscopic evaluation of both extraction 
sites. However, there was absence of exposed bone on both extraction sites. (Fig. 1)
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Fig. 1. Macroscopic assessment of the extraction sites in the pilot study. (a) Right 
mandible (post-extraction 1 month) showing a small inflammatory lesion, and (b) left 
mandible (post-extraction 2 months) showing complete mucosal coverage.
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2. Experimental design
Two skeletally mature male beagle dogs (10-month-old) with weight of 12.7 and 
12.9kg were used in the main study. Following 1 week of acclimatization, the animals 
were assigned to untreated control (CON; n=1) and zoledronic acid treated (ZOL; n=1) 
group. ZOL animal was administered with the same dose of zoledronic acid (Zometa®) 
intravenously every 10 days for 6 months, totalizing 18 administrations before extraction. 
CON animal was not treated during the experimental period.
After 6 months, all animals underwent dental extraction of the left lower premolar 2, 3, 
4 and molar 1. 1 month later, all animals underwent extraction of the right lower premolar 
2, 3, 4 and molar 1. 
1 month after the extraction of the right premolars and molar, the animals were 
euthanized by intravenous administration of sodium pentobarbital. The right and left 
mandibles were dissected and placed in 10% formalin solution.       
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3. Macroscopic assessment
Clinical analysis was performed to verify the presence of exposed bone or fistula and 
photographs were taken for documentation. 
4. Micro-CT analysis
The extraction sites of both the right and left hemi-mandibles were isolated and 
scanned by using high resolution micro-CT scanner SkyScan1173 (Bruker-microCT, 
Kartuizersweg 3B 2550 Kontich, Belgium). The tomographic images were acquired at
energy settings of 90 kV and 88μA, integration time of 500ms, filtration by 1.0mm 
aluminum, beam hardening correction 40%, and 25μm pixel size. The cross-section 
reconstruction was made by using NreconⓇ software (ver. 1.6.9.8). 
Comparing original 2D images with the segmented micro-CT scan images, a proper 
threshold was selected (82~255 mg HA/cm3). The cylindrical region of interest (ROI)
was selected and measured with CT Analyzer (ver. 1.15.4.0) software.
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Microarchitectural morphometric properties of the specimen were evaluated within the 
following ROIs; (1) center of the extraction sockets of each root, (2) center of the septal 
bone between the roots, and (3) Buccal and lingual cortical bone of each root. (Fig. 2)
Fig. 2. Region of interest. (a) Center of the extraction socket (b) Center of the septal bone 
(c) Buccal and lingual cortical bone
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(1) Trabecular bone morphology indices included were as follows;
 Total volume (TV, mm3) - Volume of the region of interest 
 Bone volume (BV, mm3) - Volume of the region segmented as trabecular bone
 Bone volume fraction (BV/TV, %) - Ratio of the segmented bone volume to the total 
volume of the ROI
 Trabecular number (Tb.N, 1/mm) - average number of trabeculae per unit length
 Trabecular thickness (Tb.Th, mm) - Mean thickness of trabeculae, assessed using 
direct 3D methods
 Trabecular separation (Tb.Sp, mm) - Mean distance between trabeculae, assessed 
using direct 3D methods
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(2) Cortical bone morphology indices included were as follows;
 Total cross-sectional area (Tt.Ar, mm2) - total cross-sectional area inside the 
periosteal envelope
 Cortical volume (Ct.V, mm3) - Volume of cortical bone compartment
 Cortical bone area (Ct.Ar, mm2) - Cortical volume (Ct.V) ÷ (number of slices ×
slice thickness
 Total pore volume (Po.V, mm3) - Total volume occupied by cortical pores in the 
region of interest 
 Pore number (Po.N, n) - Number of cortical pores in a given volume
 Cortical area fraction (Ct.Ar/Tt.Ar, %) - Ratio of cortical cross-sectional area to total
cross-sectional area
 Cortical porosity (Ct.Po, %) - Pore volume divided by the total cortical compartment 
volume
 Average pore volume (Po.V/Po.N, mm3) - Total pore volume divided by the pore 
number
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5. Histologic analysis
The extraction sockets, adjacent septal bone and cortical bone of the hemi-mandibles 
were processed for histologic analysis. Specimens were fixed with 4% phosphate-
buffered saline formalin for 2 weeks and decalcified in 10% EDTA (pH 7.2) at 4°C for 28
days and immersed in paraffin. The samples were then embedded in paraffin and cut into 
4-μm-thick sections. The sections were deparaffinized, rehydrated, and stained with 
hematoxylin and eosin (H-E). 
6. Statistical analysis
Statistical analysis was carried out using SPSS 20.0 (IBM Corp., Armonk, NY, USA). 
Microarchitectural properties were compared between CON and ZOL animals using two-
sample t tests. Difference in microarchitectural properties was compared between time 
(post-extraction 1 month and 2 months) within each group using paired t tests. A p-value 
of less than 0.05 was considered statistically significant. 
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III. RESULTS
1. Macroscopic assessment
CON animal presented normal healing process and did not exhibit exposed bone or 
fistula at both post-extraction 1 month (CON1M) and 2 months (CON2M). (Fig. 3) 
Fig. 3. Macroscopic assessment of the extraction sites in the CON animal. (a) CON1M (b) 
CON2M showing complete mucosal healing.
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ZOL animal exhibited impaired wound healing and exposed bone at all extraction sites 
at both post-extraction 1 month (ZOL1M) and 2 months (ZOL2M). (Fig. 4) 
Fig. 4. Macroscopic assessment of the extraction sites in the ZOL animal. (a) ZOL1M (b) 
ZOL2M showing impaired wound healing with exposed bone.
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2. Micro-CT and histologic images
Extraction sockets of the CON animal demonstrated newly formed bone with normal 
trabecular pattern at both post-extraction 1 month and 2 months. (Fig. 5, 6) 
Fig. 5. Representative micro-CT images of the extraction socket in the CON animal. (a) 
CON1M (b) CON2M showing sufficient bone filling.
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Fig. 6. Representative histologic images of the extraction socket in the CON animal 
(x1.25). (a) CON1M (b) CON2M showing sufficient bone healing with normal trabecular 
pattern and epithelial coverage.
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Septal bones of the CON animal showed normal trabecular pattern with intact cortical 
bone. (Fig. 7, 8) 
Fig. 7. Representative micro-CT images of the septal bone in the CON animal. (a) 
CON1M (b) CON2M showing normal trabecular pattern.
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Fig. 8. Representative histologic images of the septal bone in the CON animal (x1.25). (a) 
CON1M (b) CON2M showing normal trabecular pattern and epithelial coverage.
- 19 -
Extraction sockets of the ZOL animal presented insufficient amount of bone filling 
with extensive destruction of the pre-existing trabecular and cortical bone and sequestrum
formation, and intense periosteal reaction around the outer cortex at both post-extraction 
1 month and 2 months. (Fig. 9, 10) 
Fig. 9. Representative micro-CT images of the extraction socket in the ZOL animal. (a) 
ZOL1M (b) ZOL2M showing extensive destruction of the trabecular and cortical bone 
with sequestrum formation and intense periosteal reaction.
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Fig. 10. Representative histologic images of the extraction socket in the ZOL animal 
(x1.25). (a) ZOL1M (b) ZOL2M showing insufficient bone filling, extensive destruction 
of the trabecular and cortical bone with sequestrum formation and intense periosteal 
reaction.
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Septal bones of the ZOL animal showed destruction of the trabecular pattern and 
cortical bone with sequestrum formation with slight periosteal reaction and mucosal 
inflammation at both post-extraction 1 month and 2 months. (Fig. 11, 12) 
Fig. 11. Representative micro-CT images of the septal bone in the ZOL animal. (a) 
ZOL1M (b) ZOL2M showing destruction of the trabecular and cortical bone with 
sequestrum formation and periosteal reaction.
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Fig. 12. Representative histologic images of the septal bone in the ZOL animal (x1.25). (a) 
ZOL1M (b) ZOL2M destruction of the trabecular and cortical bone with severe mucosal 
inflammation.
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3. Micro-CT analysis
(1) Extraction sockets
Bone microarchitectural morphometric assessment of the extraction sockets of each 
root revealed significantly lower values of bone volume fraction (BV/BT) in ZOL animal 
compared to that of the CON animal at both post-extraction 1 month and 2 months, 
suggesting severely compromised socket healing. ZOL animal presented deteriorated 
architectures showing significantly lower values of trabecular number (Tb.N) and 
trabecular thickness (Tb.Th), and significantly higher values of trabecular separation 
(Tb.Sp ) than those of CON animal at both post-extraction 1 month and 2 months. In ZOL 
animal, BV/BT and Tb.N decreased significantly from post-extraction 1 month to 2 
months. 
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Fig. 13. Bone microarchitectural morphometric assessment of the extraction sockets. 
Abbreviations; BV/BT, bone volume fraction; Tb.N, trabecular number; Tb.Th, 
trabecular thickness; Tb.Sp, trabecular separation. Column and bar indicate mean and 
standard error, respectively. * indicates P<0.05 between CON and ZOL at the same post-
extraction period; ** indicates P<0.05 between post-extraction 1 month and 2 months in 
the same group.
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(2) Septal bone
Bone microarchitectural morphometric assessment of the septal bone revealed 
significantly lower values of BV/BT in ZOL animal compared to that of CON animal at 
both post-extraction 1 month and 2 months. There was no significant difference between 
the values of Tb.N, Tb.Th and Tb.Sp between ZOL and CON group.
  
     
Fig. 14. Bone microarchitectural morphometric assessment of the septal bone. * indicates 
P<0.05 between CON and ZOL at the same post-extraction period.
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(3) Cortical bone
Bone microarchitectural morphometric assessment of the cortical bone revealed 
significantly lower values cortical area fraction (Ct.Ar/Tt.Ar) and higher values of 
cortical porosity (Ct.Po) and average pore volume (Po.V/Po.N) in ZOL animal compared 
to those of CON animal at both post-extraction 1 month and 2 months. 
     
Fig. 15. Bone microarchitectural morphometric assessment of the cortical bone. 
Abbreviations; Ct.Ar/Tt.Ar, cortical area fraction; Ct.Po, cortical porosity; Po.V/Po.N, 
average pore volume. * indicates P<0.05 between CON and ZOL at the same post-
extraction period.
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III. DISCUSSION
This study was conducted to induce clinical features of MRONJ after tooth extraction 
in zoledronate treated beagle dog, and evaluate the microarchitectural changes of bone 
healing using micro-CT. The results showed that zoledronic acid (0.067mg/kg) 
administrated approximately 3 times more frequently than the oncological use for 6 
months successfully induced exposed bone at post-extraction 1 month and 2 months with 
insufficient bone fill in the extraction sockets and destruction of adjacent trabecular bone 
and cortical bone. 
Until now, various animal models of MRONJ have been reported with most of them 
being rodents. (Barba-Recreo et al., 2014; Biasotto et al., 2010; Hokugo et al., 2010; 
Lopez-Jornet et al., 2010; Maahs et al., 2011; Sharma et al., 2013; Sonis et al., 2009)
However, a potential drawback to the use of rodent models for MRONJ is the lack of 
Haversian remodeling in the rat skeleton. In humans, increased Haversian remodeling is 
the main cause of cortical porosity, but rodents lack a well-developed Haversian
remodeling system. (Kubek et al., 2010)
Recently, various trials of developing MORNJ using beagle dogs have been published. 
Yet, none of them reliably induced ONJ to satisfy the definition of MRONJ. Allen et al. 
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reported compromised bone healing of extraction sites in only one of six zoledronic acid 
treated beagle dogs, after intravenous infusion of zoledronic acid (0.067mg/kg) every 2 
weeks for 3 months. (Allen et al., 2011) Allen et al. also reported absence of exposed 
bone following dental extraction in beagle dogs treated after intravenous infusion of 
zoledronic acid (0.067mg/kg) every 2 weeks for 8 months. (Allen et al., 2013) Likewise, 
Huja et al. reported absence of ONJ lesion at surgical site in zoledronic acid treated 
beagle dogs after monthly infusion of 0.1mg/kg for 4 months. (Huja et al., 2011) From 
the variability of these study designs, it could be concluded that the frequency or the 
duration of zoledronic acid administration was insufficient to develop MRONJ model in 
beagle dogs.
However, there have been reports on successful inductions of MRONJ in other animals. 
Peutke et al. reported exposed bone following dental extraction in zoledronic acid treated 
minipigs after intravenous infusion of zoledronic acid (0.05mg/kg) every 1 week for 6 
months. (Pautke et al., 2012) Also, Voss et al. reported spontaneous development of 
exposed bone following dental extraction in sheep after intravenous infusion of higher 
dose of zoledronic acid (0.075mg/kg) every 3 weeks for 4 months. (Voss et al., 2015)
This may be attributed to the different mechanism of chewing of these animals from the 
beagle dogs. 
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This study attempted to compensate for the more rapid bone metabolism of beagle 
dogs. In the pilot study, zoledronic acid (0.067mg/kg) was administrated approximately 3 
times more frequently than the oncological used in human. However, this frequency for 3 
months duration was insufficient to develop spontaneous exposed bone after tooth 
extraction in a beagle dog. Although a small inflammatory lesion was present at the 
extraction site at postoperative 1 month, complete mucosal healing occurred at 
postoperative 2 months. Therefore, duration of zoledronic acid administration was 
increased with the same frequency. As a result, exposed bone was developed in ZOL 
animal at both at post-extraction 1 month and 2 months, while CON animal showed 
complete mucosal coverage at post-extraction 1 month and 2 months. Previous report on 
normal epithelial closure after tooth extraction in beagle dogs was within 14 days. 
(Cardaropoli et al., 2003)
In ZOL animal, the mean BV/TV of the extraction socket was 5% and 3% at post-
extraction 1 month and 2 months respectively. This was significantly lower compared to 
the mean BV/TV of 50% and 51% in CON animal, showing significantly lower amount 
of bone fill in the extraction socket and severely compromised socket healing of the ZOL 
animal. Also, Tb.N and Tb.Th was significantly lower and Tb.Sp was significantly higher
in ZOL animal compare to those of CON animal, implying deteriorated architectures of 
the newly formed bone in the extraction sockets of the ZOL animal. Significant decrease 
of BV/BT and Tb.N in ZOL animal from post-extraction 1 month to 2 months suggests 
progressive osteonecrosis over time.
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The mean BV/TV of the septal bone in ZOL animal was 17% and 15% at post-
extraction 1 month and 2 months respectively. This also was significantly lower 
compared to the mean BV/TV of 28% and 26% in CON animal, suggesting destruction of 
the trabecular bone outside the extraction socket. ZOL animal also presented lower values 
of mean Tb.N and Tb.Th and higher values of mean Tb.Sp of the septal bone compared to 
those of the CON animal, although they were not statistically significant. 
ZOL animal also showed reduction of Ct.Ar/Tt.Ar, increase in Ct.Po and Po.V/Po.N at 
both post-extraction 1M and 2M period, compared with CON animal, demonstrating 
cortical disruption. ZOL animal also presented intense periosteal bone formation on both 
buccal and lingual surface of the cortical bone. Periosteal reaction was also reported in the 
study by Allen, despite the absence of exposed bone following dental extraction. (Allen et 
al., 2013) Periosteal reaction also suggests the innate high bone healing potential of the 
beagle dogs, which makes it more time consuming to develop an MRONJ model.
Recently, there have been attempts to develop an animal model of MRONJ with 
precedent osteoporosis. (Kim et al., 2015; Voss et al., 2016) Further study is required to 
establish a beagle dog model that includes osteopenic changes prior to bisphosphonate 
treatment in order to further evaluate the pathogenesis of this condition.  
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IV. Conclusion 
Medication-related osteonecrosis of the jaws (MRONJ) is a rare but potentially severe 
side effect of long-term use of antiresorptive and antiangiogenic agents. However, the 
etiopathology of this condition is still not fully understood. In order to establish the 
pathogenesis of this disease, a reliable and reproducible animal model is required. The 
purpose of this study was to induce clinical features of MRONJ after tooth extraction in 
zoledronate treated beagle dogs and analyze bone healing using micro-CT. The results are 
as follows;
1. In the experimental animal, extraction sites showed exposed bone with impaired 
wound healing at both post-extraction 1 month and 2 months.
2. Extraction sockets of the experimental animal showed significantly lower values 
of bone volume fraction, trabecular number, and trabecular thickness than those 
of the control animal at both post-extraction 1 month and 2 months. 
3. Septal bone of the experimental animal showed significantly lower values of 
bone volume fraction than those of the control animal at both post-extraction 1 
month and 2 months. 
4. Cortical bone of the experimental animal showed significantly lower values of 
cortical area fraction, higher values of cortical porosity and average pore volume
than those of the control animal at both post-extraction 1 month and 2 months. 
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5. In the experimental animal, new bone formation noted outside buccal and lingual
cortex at both post-extraction 1 month and 2 months.
Although the sample size of this study is limited, this study introduces beagle dog as a 
promising large animal model for MRONJ. From this model, microarchitectural 
morphometric changes of bone healing after tooth extraction were evaluated. This animal 
model can be used for further research in the fields of MRONJ etiopathology and 
treatment.
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ABSTRACT (IN KOREAN)
Micro-CT를 이용한 비스포스포네이트가 투여된
비글견의 발치 후 골 치유 분석
<지도교수 정 영 수>
연세대학교 대학원 치의학과
정 승 원
약제 관련 턱뼈 괴사(Medication-related osteonecrosis of the jaw, 
MRONJ)는 비스포스포네이트, RANKL antibody 계열의 골흡수억제제 및
혈관신생억제제의 장기간 사용과 관련되어 드물게 발생하지만 때로는
심각하게 나타날 수 있는 합병증이다. 턱뼈에서만 특이적으로 괴사가
나타나는 이유에 대하여 다양한 가설이 제시되고 있으나 아직까지 명확한
발병 기전은 밝혀지지 않은 상태이다. MRONJ의 발병 기전을 밝히고 치료
방법을 개발하기 위해 소형 동물모델에 대한 여러 연구들이 보고되어 왔으나, 
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아직까지 만족할만한 대형 동물모델은 개발되지 않은 상태이다. 이번
연구에서는 비스포스포네이트가 투여된 비글견에서 발치 후 MRONJ를
유도하고, 골 치유 양상을 micro-CT를 이용하여 분석하여 다음과 같은
결과를 얻었다
1. 대조군에서는 발치 후 1개월, 2개월에서 발치와 주변의 정상적인
연조직 치유가 관찰되었으나, 실험군에서는 발치 후 1개월, 2개월에서
모두 발치와 주변의 골노출이 관찰되었다. 
2. 실험군에서는 대조군에 비해 발치 후 1개월, 2개월에서 발치와의 bone 
volume fraction, trabecular number, 그리고 trabecular thickness가
유의하게 낮게 나타났다.  
3. 실험군에서는 대조군에 비해 발치 후 1개월, 2개월에서 치간 해면골의
bone volume fraction이 유의하게 낮게 나타났다. 
4. 실험군에서는 대조군에 비해 발치 후 1개월, 2개월에서 피질골의
cortical area fraction이 유의하게 낮게, cortical porosity와 average 
pore volume은 유의하게 높게 나타났다.  
5. 실험군에서는 발치 후 1개월, 2개월에서 협설측 피질골 외측에 신생골
형성이 관찰되었다.
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이번 연구를 통해 Zoledronic acid가 투여된 비글견에서 발치 후 1개월부터
임상적으로 MRONJ의 정의에 부합하는 결과를 얻을 수 있었으며,
미세구조학적으로 심하게 손상된 발치와 주변 해면골 및 피질골의 골 구조를
확인하였다. 이 모델이 MRONJ의 병태생리 규명 및 치료 개발을 위한 연구에
사용될 수 있을 것으로 평가된다. 
핵심되는 말: 약제 관련 턱뼈 괴사, 대형 동물모델, micro-CT
